Search results for "Hallucinogens"

showing 8 items of 28 documents

MDMA Administration and Heat Shock Proteins Response: Foreseeing a Molecular Link

2010

Molecular and cellular mechanisms of MDMA-induced toxicity have been extensively studied in a number of experimental models. Nevertheless, only few studies investigated the involvement of HSPs ("molecular chaperones") in MDMA organs toxicity. In the present minireview we highlight this subject analysing the results of these studies conducted especially on brain tissue. Despite of it seems obvious that HSPs overexpression is a protective reaction against MDMA treatment, the molecular mechanisms for exerting their action are far to be undiscovered. At the same time, we need of comprehensive studies concerning the whole range of Hsps/chaperones expressions in all organs after acute and chronic…

N-Methyl-34-methylenedioxyamphetamineModels NeurologicalBrainPharmaceutical ScienceMDMABrain tissuePharmacologyBiologyHeat shock proteinmental disordersToxicityHallucinogensmedicineAnimalsHumans34-Methylenedioxy-N-methylamphetamine brain toxicity Hsp27 Hsp32 Hsp60 Hsp70.Heat-Shock ProteinsHeat-Shock Responsepsychological phenomena and processesBiotechnologymedicine.drugCurrent Pharmaceutical Biotechnology
researchProduct

Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis

2020

The fully automated system of single drop microextraction coupled with capillary electrophoresis (SDME-CE) was developed for in-line preconcentration and determination of muscimol (MUS) and psilocin (PSC) from urine samples. Those two analytes are characteristic active metabolites of Amanita and Psilocybe mushrooms, evoking visual and auditory hallucinations. Study analytes were selectively extracted from the donor phase (urine samples, pH 4) into the organic phase (a drop of octanol layer), and re-extracted to the acidic acceptor (background electrolyte, BGE), consisting of 25 mM phosphate buffer (pH 3). The optimized conditions for the extraction procedure of a 200 &micro

OctanolAnalyteLiquid Phase MicroextractionCalibration curveAmanitacapillary electrophoresisPharmaceutical ScienceElectrolyteUrinesingle drop microextraction01 natural sciencesArticleAnalytical Chemistrylcsh:QD241-44103 medical and health scienceschemistry.chemical_compound0302 clinical medicineCapillary electrophoresislcsh:Organic chemistryLimit of DetectionDrug DiscoverymedicineHumans030216 legal & forensic medicinePhysical and Theoretical ChemistrypsilocinChromatographyChemistrygreen chemistry010401 analytical chemistryOrganic ChemistryElectrophoresis CapillaryHydrogen-Ion ConcentrationmuscimolurinePsilocybin0104 chemical sciencesDilutionChemistry (miscellaneous)PsilocinCalibrationHallucinogensSolventsMolecular MedicinePsilocybemedicine.drugMolecules
researchProduct

Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and …

2021

AbstractBackgroundFirst episode psychosis (FEP) patients who use cannabis experience more frequent psychotic and euphoric intoxication experiences compared to controls. It is not clear whether this is consequent to patients being more vulnerable to the effects of cannabis use or to their heavier pattern of use. We aimed to determine whether extent of use predicted psychotic-like and euphoric intoxication experiences in patients and controls and whether this differs between groups.MethodsWe analysed data on patients who had ever used cannabis (n = 655) and controls who had ever used cannabis (n = 654) across 15 sites from six countries in the EU-GEI study (2010–2015). We used multiple regres…

SYMPTOMSPoison control0302 clinical medicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.substance abuseApplied PsychologyPOPULATIONRISKeducation.field_of_studybiologyHuman factors and ergonomicsCannabis usePsychotomimeticSubstance abusePsychiatry and Mental healthSchizophreniaPsychotic-like experiencepsychotomimeticmedicine.drugmedicine.medical_specialtyDISORDERSPopulationFrequency of use03 medical and health sciencesFirst episode psychosisInjury preventionmedicineHumansAssociation (psychology)PsychiatryeducationSettore MED/25 - PsichiatriaDELUSIONAL IDEATIONEffects of cannabisMETAANALYSISCannabisCannabinoid Receptor Agonistsbusiness.industryPsychotic-like experiencesbiology.organism_classificationmedicine.disease030227 psychiatryschizophreniaMulti nationalPsychotic DisordersHallucinogensPOTENCYCannabisbusiness030217 neurology & neurosurgery
researchProduct

Nanosensor for Sensitive Detection of the New Psychedelic Drug 25I-NBOMe.

2020

[EN] This work reports the synthesis, characterization, and sensing behavior of a hybrid nanodevice for the detection of the potent abuse drug 25I-NBOMe. The system is based on mesoporous silica nanoparticles, loaded with a fluorescent dye, functionalized with a serotonin derivative and capped with the 5-HT2A receptor antibody. In the presence of 25I-NBOMe the capping antibody is displaced, leading to pore opening and rhodamine B release. This delivery was ascribed to 5-HT2A receptor antibody detachment from the surface due to its stronger coordination with 25I-NBOMe present in the solution. The prepared nanodevice allowed the sensitive (limit of detection of 0.6 mm) and selective recogniti…

SerotoninMesoporous silica nanoparticles25I-NBOMehallucinogenic drugsMescalinesensorsCatalysischemistry.chemical_compoundAgonist 5-HT2A serotonin receptorQUIMICA ORGANICAQUIMICA ANALITICAmedicineRhodamine BHumansmesoporous silica nanoparticlesNanodeviceLysergic acid diethylamideDetection limitSensorsQUIMICA INORGANICAOrganic ChemistryMDMAGeneral ChemistryMesoporous silicaHallucinogenic drugs25I-NBOMeCombinatorial chemistrychemistryDimethoxyphenylethylamine25I-NBOMe agonist 5-HT2A serotonin receptor hallucinogenic drugs mesoporous silica nanoparticles sensorsHallucinogensagonist 5-HT2A serotonin receptormedicine.drug
researchProduct

Unconventional ligands and modulators of nicotinic receptors

2002

Evidence gathered from epidemiologic and behavioral studies have indicated that neuronal nicotinic receptors (nAChRs) are intimately involved in the pathogenesis of a number of neurologic disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. In the mammalian brain, neuronal nAChRs, in addition to mediating fast synaptic transmission, modulate fast synaptic transmission mediated by the major excitatory and inhibitory neurotransmitters glutamate and GABA, respectively. Of major interest, however, is the fact that the activity of the different subtypes of neuronal nAChR is also subject to modulation by substances of endogenous origin such as choline, the tryptophan …

SerotoninNeuroactive steroidPsychotomimetic drugReceptors NicotinicNeurotransmissionPharmacologyBiologyKynurenic AcidLigandsInhibitory postsynaptic potentialCholineCellular and Molecular Neurosciencechemistry.chemical_compoundKynurenic acidmental disordersmedicineAnimalsHumansPhencyclidineAnestheticsAmyloid beta-PeptidesGalantamineGeneral NeuroscienceGlutamate receptorNicotinic agonistnervous systemchemistryHallucinogensSteroidsNeurosciencemedicine.drugJournal of Neurobiology
researchProduct

Short-Term Stability of Lysergic Acid Diethylamide (LSD), N-Desmethyl-LSD, and 2-Oxo-3-hydroxy-LSD in Urine, Assessed by Liquid Chromatography–Tandem…

2002

Lysergic acid diethylamide (LSD) is one of the most potent hallucinogenic agents known. Recently, data on emergency department episodes related to the use of drugs commonly thought as “club drugs” have also included LSD (1). Confirmation of LSD use by testing biological fluids is still an analytical challenge because of its extensive, rapid metabolism and its instability (2)(3)(4). After ingestion of a typical street dose (40–120 μg), the concentration of LSD in urine falls to <1 μg/L within a few hours (2)(5)(6). Recently, N -desmethyl-LSD (nor-LSD) and 2-oxo-3-hydroxy-LSD (O-H-LSD) have been identified as LSD metabolites in human urine (7)(8). Measured nor-LSD concentrations were reported…

Time FactorsChromatographyChemistryBiochemistry (medical)Clinical BiochemistryMetabolismUrineMass spectrometryMass SpectrometryLysergic Acid DiethylamideDrug StabilityLiquid chromatography–mass spectrometryHallucinogensUltraviolet lightmedicineHumansIngestionQuantitative analysis (chemistry)Chromatography LiquidLysergic acid diethylamidemedicine.drugClinical Chemistry
researchProduct

Bioactive alkaloids of hallucinogenic mushrooms

2015

The aim of our chapter is to review recent developments in a group of medicinally important natural products–alkaloids, with reference to the structure–activity studies in respect of certain diseases. Alkaloids covered by our review come from mushrooms called “hallucinogenic.” Hallucinogenic compounds have been chemically identified in mushrooms belonging to various genera, e.g., Agrocybe, Amanita, Conocybe, Galerina, Gymnopilus, Hypholoma, Inocybe, Panaeolus, Psilocybe, Pholiotina, Pluteus, and Weraroa [J.W. Allen, Ethnomycol. J. Sacred Mushroom Stud. 9 (2012) 130–175]. One of the largest classes of alkaloids is indole alkaloids. Indoles are probably the most widely distributed heterocycli…

determinationAmanitahallucinogensPsilocybeisolation
researchProduct

Psilocybin as an inducer of ego death and similar experiences of religious provenance

2016

The purpose of this chapter is to provide an overview of the impact of hallucinogenic psilocybin on religious-type emotionality related to ego disintegration. Psilocybin as a typical hallucinogen evokes alternations of visual perception (enhances a development of pseudo-hallucinations, phantom visual perception, or hypnagogic experiences). These visual phenomena may be inspiring and are claimed to enhance aesthetic appreciation. Additionally the hallucinogen induces transient impairment of cognitive functions and psychological regression comparable to the signs of ego blurring and dissociative phenomena. The psilocybin effects, initially euphoric, may become emotionally perceived as anxious…

schizophreniaego deathhallucinogenspsychoanalysisego disintegrationmysticismpsilocybin
researchProduct